Tuesday, October 14, 2025

Most Read of the Week

spot_img

Latest Articles

Beyond Letters: Misconceptions and Scientific Facts About Dyslexia

Dyslexia: Definition, Causes, Prevalence, Misconceptions, and Treatment Approaches

Dyslexia is a neurodevelopmental learning disorder characterized by persistent difficulties in reading, writing, and spelling. In the DSM-5 classification of the American Psychiatric Association, it is included under the category of “Specific Learning Disorder” and is particularly defined as a reading impairment. This condition is not related to an individual’s intelligence; dyslexia can also occur in individuals with average or superior intelligence.

The causes of dyslexia are multifactorial. From a neurobiological perspective, differences have been identified in the reading and language-processing areas of the left hemisphere of the brain (temporo-parietal and occipito-temporal regions). Genetic studies suggest that a family history of dyslexia is a significant risk factor, and some genes (e.g., DCDC2, KIAA0319) have been found to be associated with the condition. Environmental factors such as limited early literacy experiences, low socioeconomic status, and delays in language development also contribute to risk, but they are not solely determinative.

Early Signs and Identification of Dyslexia

Dyslexia is most commonly identified during the early school years (ages 7–9). As children begin to learn to read and write, difficulties in letter-sound correspondence, reduced reading fluency, frequent spelling errors, and problems with reading comprehension become apparent. However, certain early indicators may also be observed during the preschool years, such as difficulty with rhyming, problems with verbal memory, or confusion with directions.

Common Misconceptions About Dyslexia

In society, there are many misconceptions about dyslexia. The most common is equating dyslexia with intellectual disability. In fact, dyslexia is not related to general intelligence, and the majority of individuals with dyslexia have average or above-average intelligence (Snowling, 2013).

Another common misconception is that dyslexia is merely about writing letters backward. Letter reversal is a temporary phase often seen in the early stages of literacy development; dyslexia, however, is a much broader language-processing difficulty (Vellutino, Fletcher, Snowling, & Scanlon, 2004).

Additionally, beliefs that dyslexia will resolve spontaneously or that it is a rare condition contradict scientific evidence. Dyslexia is a lifelong condition, but with appropriate educational interventions, individuals can make significant progress in reading and writing skills (Lyon, Shaywitz, & Shaywitz, 2003).

Regarding prevalence, international studies report that dyslexia affects approximately 5–10% of the child population (Peterson & Pennington, 2015). Another misconception is that a single instructional method can remediate dyslexia in all cases. In reality, dyslexia is heterogeneous, and interventions must be tailored to individual needs (Snowling & Hulme, 2012).

Treatment and Educational Interventions

There is no direct pharmacological treatment developed specifically for dyslexia. Dyslexia is a neurodevelopmental condition associated with structural and functional differences in the brain, particularly in language and reading-related regions of the left hemisphere (Shaywitz & Shaywitz, 2008). Therefore, treatment primarily relies on specialized educational programs.

Effective interventions include individualized instructional methods, multisensory approaches, and structured literacy programs. The Orton-Gillingham approach, for instance, is one of the best-known methods, supporting reading development by simultaneously engaging visual, auditory, and kinesthetic channels (Ritchey & Goeke, 2006).

Comorbidity and Pharmacological Support

Moreover, individuals with dyslexia often present with comorbid conditions such as Attention-Deficit/Hyperactivity Disorder (ADHD). Research indicates that dyslexia and ADHD co-occur in approximately 30–40% of cases (Germanò, Gagliano, & Curatolo, 2010). In such cases, stimulant medications such as methylphenidate may be prescribed by physicians solely to alleviate ADHD symptoms.

Medication can improve attention, concentration, and impulse control, thereby indirectly enhancing the effectiveness of educational interventions (Bental & Tirosh, 2008). However, it must be emphasized that pharmacological treatment does not directly eliminate dyslexia.

Conclusion

In conclusion, dyslexia is a lifelong learning difficulty that can be managed with early diagnosis and appropriate educational interventions. Correcting misconceptions is critical for both families and educators to provide effective guidance. The academic literature consistently highlights that individualized and multifaceted educational approaches significantly enhance the academic performance and psychosocial adjustment of individuals with dyslexia.

References

Bental, B., & Tirosh, E. (2008). The effects of methylphenidate on word decoding accuracy in boys with attention-deficit/hyperactivity disorder. Journal of Clinical Psychopharmacology, 28(1), 89–92. https://doi.org/10.1097/jcp.0b013e3181607e19

Germanò, E., Gagliano, A., & Curatolo, P. (2010). Comorbidity of ADHD and dyslexia. Developmental Neuropsychology, 35(5), 475–493. https://doi.org/10.1080/87565641.2010.494748

Lyon, G. R., Shaywitz, S. E., & Shaywitz, B. A. (2003). A definition of dyslexia. Annals of Dyslexia, 53(1), 1–14. https://doi.org/10.1007/s11881-003-0001-9

Peterson, R. L., & Pennington, B. F. (2015). Developmental dyslexia. Annual Review of Clinical Psychology, 11, 283–307. https://doi.org/10.1146/annurev-clinpsy-032814-112842

Ritchey, K. D., & Goeke, J. L. (2006). Orton-Gillingham and Orton-Gillingham–based reading instruction: A review of the literature. The Journal of Special Education, 40(3), 171–183. https://doi.org/10.1177/00224669060400030501

Shaywitz, S. E., & Shaywitz, B. A. (2008). Paying attention to reading: The neurobiology of reading and dyslexia. Development and Psychopathology, 20(4), 1329–1349. https://doi.org/10.1017/S0954579408000631

Snowling, M. J. (2013). Early identification and interventions for dyslexia: A contemporary view. Journal of Research in Special Educational Needs, 13(1), 7–14. https://doi.org/10.1111/j.1471-3802.2012.01262.x

Snowling, M. J., & Hulme, C. (2012). Interventions for children’s language and literacy difficulties. International Journal of Language & Communication Disorders, 47(1), 27–34. https://doi.org/10.1111/j.1460-6984.2011.00081.x

Vellutino, F. R., Fletcher, J. M., Snowling, M. J., & Scanlon, D. M. (2004). Specific reading disability (dyslexia): What have we learned in the past four decades? Journal of Child Psychology and Psychiatry, 45(1), 2–40. https://doi.org/10.1046/j.0021-9630.2003.00305.x

Tutkunur Ünlü
Tutkunur Ünlü
Hello, I’m Clinical Psychologist Tutkunur Ünlü. I am currently pursuing my master’s degree in Addiction and Anti-Doping Studies at Ankara University Institute of Health Sciences. I completed my undergraduate studies in Social Work and English Psychology with honors in just three years. My main areas of focus include neurodevelopmental disorders (ADHD, learning difficulties, autism spectrum traits), addiction, anxiety, and depression. I work with both children and adults, providing evidence-based psychological support tailored to each client’s individual needs. In addition to individual therapy, I offer family-based interventions, psychoeducation programs, and consultancy services on digital addiction. My academic research primarily focuses on screen addiction, loneliness, hyperfocus, and the relationship between anxiety and depression.

Popular Articles